rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Regentis Biomaterials Ltd.

RGNT · NYSE American

Health CareMedical DevicesNot moving yet

RGNT stood above a rising 150-day average in 0 of the last 10 weekly readings. It is 40.6% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 10
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
6 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 10 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders6+3 on the quarter
New · exited4 · 1
Reported value$3.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Rosalind Advisors, Inc.added · filed 14 Aug 2026701,685$2.5M+450,175+179.0%
Warberg Asset Management LLCnew · filed 11 Aug 202686,980$306K+86,980
JANE STREET GROUP, LLCnew · filed 14 Aug 202643,333$153K+43,333
RENAISSANCE TECHNOLOGIES LLCnew · filed 13 Aug 202613,348$47K+13,348
UBS Group AGadded · filed 13 Aug 2026434$1,532+100+29.9%
Tower Research Capital LLC (TRC)new · filed 11 Aug 202611$39+11
31 Dec 2025 – 30 Jun 2026
356Dec 25Mar 26Jun 26

News

Everyone who traded it

Efraim Cohen-Arazi Company insiderDirector · last 9 Jul 20260 · 0
Ehud Geller Company insiderChief Executive Officer · last 9 Jul 20260 · 0
Jeff Dykan Company insiderDirector · last 9 Jul 20260 · 0
Keith Valentine Company insiderDirector · last 9 Jul 20260 · 0
Pini Ben-Elazar Company insiderDirector · last 9 Jul 20260 · 0
Susan Alpert Company insiderDirector · last 9 Jul 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-147%
Cash conversionFY 2025 · to 31 Dec 2024-13.4%
Debt to equityFY 2025 · to 31 Dec 20250.25×
Interest coverFY 2025 · to 31 Dec 2025-88.20×
Share count trendFY 2025 · to 31 Dec 2024-6.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$7.4M

Analyst forecasts

No analyst forecasts yet.